Gilead can now attempt at takeover of Galapagos

The Dutch economic and financial daily Het Financieele Dagblad today has reviewed the press release issued by Belgian-Dutch biotech company Galapagos to announce that Van Herk Investments’ stake in the company has decreased to 9.91% due to dilution. As a direct result, the company is now vulnerable to a takeover by Gilead, which already owns 13% of the group’s shares.